Becton Dickinson acquires Edwards Lifesciences' Critical Care product group for $4.2bn cash.
Becton Dickinson (BDX) has agreed to acquire Edwards Lifesciences' (EW) Critical Care product group for $4.2bn in cash to expand its range of medical monitoring products. The transaction is expected to close before the end of the calendar year and will immediately add to BD's revenue growth, profitability and adjusted earnings per share. The Critical Care business, based in Irvine, California, generated over $900m in revenue last year and has around 4,500 employees.
June 03, 2024
10 Articles